Table 1 Characteristics of patients with LAPA treated with induction chemotherapy (n = 234)
Sex ratio (M/F) | 2 (121/103) | Â |
Mean age (range) | 67 (29–89) |  |
Performance statusa(%) | ||
 0–1 | 215 (92) |  |
 2–3 | 19 (8) |  |
Mean BMIa(range) | 24 (14–42) |  |
Weight loss > 5% body weighta(%) | 160 (68) |  |
Diabetes (%) | 15 (36) | Â |
Back paina(%) | 152 (65) | Â |
Jaundice (%) | 136 (84)b | Â |
CA 19–9 serum levela(UI) (range) | 2292 (7–88,300) |  |
Tumour location (%) | ||
 Head | 161 (69) |  |
 Body | 57 (24) |  |
 Tail | 16 (7) |  |
Tumour classification (%) | ||
 Borderline | 158 (68) |  |
 Locally advanced | 76 (32) |  |
Arterial invasiona(%) | 93 (40) | Â |
Induction regimen (%) | Â | |
 FOLFIRINOX | 168 (72) |  |
 Gemcitabine | 66 (28) |  |
Mean number of cycles before restaging (range) | 6 (4–8) |  |
Explorative laparotomy (%) | 45 (19) | Â |
Treatment after restaging/laparotomy (%) and mean number of cycles (range) after restaging/laparotomy | ||
 FOLFIRINOX | 78 (33) | 4 (0–18) |
 Gemcitabine | 30 (12) | 4 (0–15) |
 Chemoradiation | 126 (54) | 2 (0–19) |